Interferon-gamma release assay and Rifampicin therapy for household contacts of tuberculosis

Jann Yuan Wang, Chin Chung Shu, Chih Hsin Lee, Chong Jen Yu, Li Na Lee, Pan Chyr Yang

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objectives: Longitudinal studies in household contacts to identify subgroups at risk of active tuberculosis are lacking. Methods: Household contacts of pulmonary tuberculosis patients were prospectively enrolled to receive chest radiography, sputum studies, and T-SPOT.TB assay at initial visit. Repeat examinations every 6 months for 3 years, and 4-month rifampin preventive therapy for T-SPOT.TB-positive contacts were provided. We investigated factors predicting T-SPOT.TB-positivity and active pulmonary tuberculosis. Results: 583 contacts were enrolled with a follow-up duration of 20.7±9.4 months. 176 (30.2%) were T-SPOT.TB-positive initially and 32 (18.2%) of them received preventive therapy. Old age, living in the same room/house with the index case, the index case having a high smear grade (3+~4+) and pulmonary cavitation were associated with T-SPOT.TB-positivity. Active tuberculosis developed in 9T-SPOT.TB-positive contacts; risk factors included T-SPOT.TB-positivity without preventive therapy, living in the same room, and the index case being ≤50 years or female. 108 (61.4%) T-SPOT.TB-positive contacts had repeat examinations. Forty-five had T-SPOT.TB reversion and none of them developed active tuberculosis. Conclusion: Household contacts who are T-SPOT.TB-positive and live in the same room as the index case are at risk of active tuberculosis and require preventive therapy and close follow-up.

Original languageEnglish
Pages (from-to)291-298
Number of pages8
JournalJournal of Infection
Volume64
Issue number3
DOIs
Publication statusPublished - Mar 2012
Externally publishedYes

Fingerprint

Interferon-gamma Release Tests
Rifampin
Tuberculosis
Pulmonary Tuberculosis
Therapeutics
Sputum
Radiography
Longitudinal Studies
Thorax
Lung

Keywords

  • Household contact
  • Latent tuberculosis infection
  • Pulmonary tuberculosis
  • Risk factor
  • T-SPOT.TB
  • Taiwan

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Interferon-gamma release assay and Rifampicin therapy for household contacts of tuberculosis. / Wang, Jann Yuan; Shu, Chin Chung; Lee, Chih Hsin; Yu, Chong Jen; Lee, Li Na; Yang, Pan Chyr.

In: Journal of Infection, Vol. 64, No. 3, 03.2012, p. 291-298.

Research output: Contribution to journalArticle

Wang, Jann Yuan ; Shu, Chin Chung ; Lee, Chih Hsin ; Yu, Chong Jen ; Lee, Li Na ; Yang, Pan Chyr. / Interferon-gamma release assay and Rifampicin therapy for household contacts of tuberculosis. In: Journal of Infection. 2012 ; Vol. 64, No. 3. pp. 291-298.
@article{bd8b2316e4244991a29dffe42df59e5d,
title = "Interferon-gamma release assay and Rifampicin therapy for household contacts of tuberculosis",
abstract = "Objectives: Longitudinal studies in household contacts to identify subgroups at risk of active tuberculosis are lacking. Methods: Household contacts of pulmonary tuberculosis patients were prospectively enrolled to receive chest radiography, sputum studies, and T-SPOT.TB assay at initial visit. Repeat examinations every 6 months for 3 years, and 4-month rifampin preventive therapy for T-SPOT.TB-positive contacts were provided. We investigated factors predicting T-SPOT.TB-positivity and active pulmonary tuberculosis. Results: 583 contacts were enrolled with a follow-up duration of 20.7±9.4 months. 176 (30.2{\%}) were T-SPOT.TB-positive initially and 32 (18.2{\%}) of them received preventive therapy. Old age, living in the same room/house with the index case, the index case having a high smear grade (3+~4+) and pulmonary cavitation were associated with T-SPOT.TB-positivity. Active tuberculosis developed in 9T-SPOT.TB-positive contacts; risk factors included T-SPOT.TB-positivity without preventive therapy, living in the same room, and the index case being ≤50 years or female. 108 (61.4{\%}) T-SPOT.TB-positive contacts had repeat examinations. Forty-five had T-SPOT.TB reversion and none of them developed active tuberculosis. Conclusion: Household contacts who are T-SPOT.TB-positive and live in the same room as the index case are at risk of active tuberculosis and require preventive therapy and close follow-up.",
keywords = "Household contact, Latent tuberculosis infection, Pulmonary tuberculosis, Risk factor, T-SPOT.TB, Taiwan",
author = "Wang, {Jann Yuan} and Shu, {Chin Chung} and Lee, {Chih Hsin} and Yu, {Chong Jen} and Lee, {Li Na} and Yang, {Pan Chyr}",
year = "2012",
month = "3",
doi = "10.1016/j.jinf.2011.11.028",
language = "English",
volume = "64",
pages = "291--298",
journal = "Journal of Infection",
issn = "0163-4453",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Interferon-gamma release assay and Rifampicin therapy for household contacts of tuberculosis

AU - Wang, Jann Yuan

AU - Shu, Chin Chung

AU - Lee, Chih Hsin

AU - Yu, Chong Jen

AU - Lee, Li Na

AU - Yang, Pan Chyr

PY - 2012/3

Y1 - 2012/3

N2 - Objectives: Longitudinal studies in household contacts to identify subgroups at risk of active tuberculosis are lacking. Methods: Household contacts of pulmonary tuberculosis patients were prospectively enrolled to receive chest radiography, sputum studies, and T-SPOT.TB assay at initial visit. Repeat examinations every 6 months for 3 years, and 4-month rifampin preventive therapy for T-SPOT.TB-positive contacts were provided. We investigated factors predicting T-SPOT.TB-positivity and active pulmonary tuberculosis. Results: 583 contacts were enrolled with a follow-up duration of 20.7±9.4 months. 176 (30.2%) were T-SPOT.TB-positive initially and 32 (18.2%) of them received preventive therapy. Old age, living in the same room/house with the index case, the index case having a high smear grade (3+~4+) and pulmonary cavitation were associated with T-SPOT.TB-positivity. Active tuberculosis developed in 9T-SPOT.TB-positive contacts; risk factors included T-SPOT.TB-positivity without preventive therapy, living in the same room, and the index case being ≤50 years or female. 108 (61.4%) T-SPOT.TB-positive contacts had repeat examinations. Forty-five had T-SPOT.TB reversion and none of them developed active tuberculosis. Conclusion: Household contacts who are T-SPOT.TB-positive and live in the same room as the index case are at risk of active tuberculosis and require preventive therapy and close follow-up.

AB - Objectives: Longitudinal studies in household contacts to identify subgroups at risk of active tuberculosis are lacking. Methods: Household contacts of pulmonary tuberculosis patients were prospectively enrolled to receive chest radiography, sputum studies, and T-SPOT.TB assay at initial visit. Repeat examinations every 6 months for 3 years, and 4-month rifampin preventive therapy for T-SPOT.TB-positive contacts were provided. We investigated factors predicting T-SPOT.TB-positivity and active pulmonary tuberculosis. Results: 583 contacts were enrolled with a follow-up duration of 20.7±9.4 months. 176 (30.2%) were T-SPOT.TB-positive initially and 32 (18.2%) of them received preventive therapy. Old age, living in the same room/house with the index case, the index case having a high smear grade (3+~4+) and pulmonary cavitation were associated with T-SPOT.TB-positivity. Active tuberculosis developed in 9T-SPOT.TB-positive contacts; risk factors included T-SPOT.TB-positivity without preventive therapy, living in the same room, and the index case being ≤50 years or female. 108 (61.4%) T-SPOT.TB-positive contacts had repeat examinations. Forty-five had T-SPOT.TB reversion and none of them developed active tuberculosis. Conclusion: Household contacts who are T-SPOT.TB-positive and live in the same room as the index case are at risk of active tuberculosis and require preventive therapy and close follow-up.

KW - Household contact

KW - Latent tuberculosis infection

KW - Pulmonary tuberculosis

KW - Risk factor

KW - T-SPOT.TB

KW - Taiwan

UR - http://www.scopus.com/inward/record.url?scp=84856598035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856598035&partnerID=8YFLogxK

U2 - 10.1016/j.jinf.2011.11.028

DO - 10.1016/j.jinf.2011.11.028

M3 - Article

C2 - 22207002

AN - SCOPUS:84856598035

VL - 64

SP - 291

EP - 298

JO - Journal of Infection

JF - Journal of Infection

SN - 0163-4453

IS - 3

ER -